C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the AACR Annual Meeting 2021
Go back to C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the AACR Annual Meeting 2021| Cache Capital Corp. (NASDAQ: CCCC) | Delayed: 6.72 -0.19 (2.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.91 | 52 Week High | $0.30 | |||
| Open | $6.80 | 52 Week Low | $0.30 | |||
| Day High | $7.16 | P/E | N/A | |||
| Day Low | $6.53 | EPS | $0.00 | |||
| Volume | 1,725,902 | |||||
